Synchron

New York, NY · Founded 2016 · Privately Held (backing)

Developer of an implantable stent-rode designed to create a brain-computer interface. Synchron is based in New York, NY and was founded in 2016. It was valued at $385 million at its later-stage round in Dec 2022, the last priced event on record. It has raised $340 million across 1 recorded round; the latest was a $49.9 million early-stage round in Nov 2022.

PMV mark · valuation
$385.0M
Oct 2026
Priced at
its later-stage round
Dec 2022
Total raised
$339.9M
Last round
Early Stage VC
Nov 2022

Who backs Synchron?

47 investors
InvestorType
Alumni VenturesVenture capital
Khosla VenturesVenture capital
United States Department of War—
National Institutes of HealthOther
In-Q-TelVenture capital
K5 GlobalVenture capital
Greenoaks Capital PartnersVenture capital
ARCH Venture PartnersVenture capital
Qatar Investment AuthorityAsset manager
Moore Strategic VenturesVenture capital
+ 37 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Synchron investors

47 investors are on record for Synchron, including Alumni Ventures, Khosla Ventures, United States Department of War and National Institutes of Health. By type, the record holds 12 venture capital firms and 1 family office. The early-stage round in Nov 2022 drew 22 investors.

Free account
More of Synchron with a free account
  • ·The complete investor list: 47 names
  • ·Watch Synchron: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 47 firms already write checks for companies like Synchron. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View